Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 354-359 , September 2009

Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke

  • Li-Fen Lu, MD

      Affiliations

    • Division of Cardiac Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Sheng-Shan Yang, MD

      Affiliations

    • Lee's Endocrinologic Clinic, Pingtung, Taiwan
    • ,
  • Chao-Ping Wang, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Wei-Chin Hung, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Teng-Hung Yu, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Cheng-An Chiu, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Fu-Mei Chung, MS

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Shyi-Jang Shin, MD, PhD

      Affiliations

    • Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Yau-Jiunn Lee, MD, PhD

      Affiliations

    • Lee's Endocrinologic Clinic, Pingtung, Taiwan
    • Corresponding Author InformationAddress correspondence to Yau-Jiunn Lee, MD, PhD, Lee's Endocrinologic Clinic, No. 130 Min-Tzu Rd, Pingtung 90000, Taiwan.

Received 16 October 2008 ,Revised 30 December 2008 ,Accepted 6 January 2009.

References 

  1. Arner P. Insulin resistance in type 2 diabetes–role of the adipokines. Curr Mol Med. 2005;5:333–339
  2. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab. 2005;19:637–647
  3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–919
  4. Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431–1437
  5. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430
  6. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002;32:3225–3234
  7. Koczan D, Guthke R, Thiesen HJ, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol. 2005;15:251–257
  8. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318–1327
  9. Ognjanovic S, Ku TL, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium. Am J Obstet Gynecol. 2005;193:273–282
  10. Ognjanovic S, Bryant-Greenwood GD. Pre-B cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051–1058
  11. van der Veer E, Nong Z, O'Neil C, et al. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res. 2005;97:25–34
  12. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91:295–299
  13. Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006;91:1578–1581
  14. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:1198–1201
  15. Chen MP, Tsai JC, Chung FM, et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol. 2005;25:821–826
  16. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular disease III. Stroke. 1990;21:637–676
  17. Chung FM, Tsai JCR, Chang DM, et al. Peripheral total and differential leukocyte count in diabetic nephropathy: The relationship of plasma leptin to leukocytosis. Diabetes Care. 2005;28:1710–1717
  18. Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab. 2006;91:1181–1184
  19. Ognjanovic S, Tashima LS, Bryant-Greenwood GD. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol. 2003;189:1187–1195
  20. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol. 2003;41:37S–42S
  21. Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: Possible role in inflammation and plaque destabilization. Circulation. 2007;115:972–980
  22. Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol. 2005;185:R1–R8
  23. Kralisch S, Klein J, Lossner U, et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2005;289:E586–E590
  24. Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54:2911–2916
  25. Hug C, Lodish HF. Medicine, visfatin: A new adipokine. Science. 2005;307:366–367
  26. Arner P. Visfatin–a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91:28–30
  27. Wang P, van Greevenbroek MM, Bouwman FG, et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch. 2007;454:971–976

 Supported by the National Science Council and the E-Da Hospital of the Republic of China, Taiwan, under Contract No. NSC 95-2314-B-475-001 and EDAH-97I001.

PII: S1052-3057(09)00018-4

doi: 10.1016/j.jstrokecerebrovasdis.2009.01.003

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 5 , Pages 354-359 , September 2009

Article Tools

* Image Usage & Resolution